Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial.

Seibold JR, Korn JH, Simms R, Clements PJ, Moreland LW, Mayes MD, Furst DE, Rothfield N, Steen V, Weisman M, Collier D, Wigley FM, Merkel PA, Csuka ME, Hsu V, Rocco S, Erikson M, Hannigan J, Harkonen WS, Sanders ME
Ann Intern Med. 2000 132 (11): 871-9

PMID: 10836913 · DOI:10.7326/0003-4819-132-11-200006060-00004

MeSH Terms (18)

Adolescent Adult Aged Analysis of Variance Anemia Dose-Response Relationship, Drug Double-Blind Method Drug Eruptions Exanthema Female Humans Male Menorrhagia Middle Aged Placebos Recombinant Proteins Relaxin Scleroderma, Systemic

Connections (1)

This publication is referenced by other Labnodes entities: